应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01672 歌礼制药-B
复活节星期一休市 04-17 16:08:09
4.940
-0.240
-4.63%
最高
5.290
最低
4.900
成交量
679.02万
今开
5.180
昨收
5.180
日振幅
7.53%
总市值
47.57亿
流通市值
47.57亿
总股本
9.63亿
成交额
3,436万
换手率
0.71%
流通股本
9.63亿
市净率
2.27
ROE
-13.97%
每股收益
-0.32
52周最高
9.280
52周最低
0.760
市盈率
-15.44
股息
0.00
股息收益率
0.00
ROA
-10.96%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
歌礼制药-B:斥资回购,股权行使
和讯网 · 01:21
歌礼制药-B:斥资回购,股权行使
歌礼制药-B(01672)4月17日斥资49.66万港元回购10万股
智通财经 · 04-17
歌礼制药-B(01672)4月17日斥资49.66万港元回购10万股
歌礼制药-B盘中异动 早盘股价大跌5.02%报4.920港元
市场透视 · 04-17
歌礼制药-B盘中异动 早盘股价大跌5.02%报4.920港元
歌礼制药-B(01672)4月16日斥资51.91万港元回购10万股
智通财经 · 04-16
歌礼制药-B(01672)4月16日斥资51.91万港元回购10万股
歌礼制药-B04月16日遭主力抛售392万元
市场透视 · 04-16
歌礼制药-B04月16日遭主力抛售392万元
港股医药股持续走弱,歌礼制药跌超10%,药明生物跌超5%
每日经济新闻 · 04-16
港股医药股持续走弱,歌礼制药跌超10%,药明生物跌超5%
歌礼制药-B盘中异动 股价大跌5.28%报5.920港元
市场透视 · 04-16
歌礼制药-B盘中异动 股价大跌5.28%报5.920港元
歌礼制药-B(01672)因购股权获行使 合计发行11.3万股
智通财经 · 04-15
歌礼制药-B(01672)因购股权获行使 合计发行11.3万股
港股异动 | 歌礼制药-B(01672)早盘涨超12% 去年公司管线做出重大战略调整 减肥药物效果优异
智通财经网 · 04-15
港股异动 | 歌礼制药-B(01672)早盘涨超12% 去年公司管线做出重大战略调整 减肥药物效果优异
港股生物医药B类股逆势活跃,歌礼制药-B涨超8%
老虎资讯综合 · 04-15
港股生物医药B类股逆势活跃,歌礼制药-B涨超8%
歌礼制药-B04月14日主力净流入224万元 散户资金抛售
市场透视 · 04-14
歌礼制药-B04月14日主力净流入224万元 散户资金抛售
歌礼制药-B盘中异动 快速上涨6.34%报5.700港元
市场透视 · 04-14
歌礼制药-B盘中异动 快速上涨6.34%报5.700港元
歌礼制药-B03月11日主力净流入124万元 散户资金抛售
市场透视 · 03-11
歌礼制药-B03月11日主力净流入124万元 散户资金抛售
歌礼制药-B盘中异动 股价大跌5.93%报6.820港元
市场透视 · 03-11
歌礼制药-B盘中异动 股价大跌5.93%报6.820港元
歌礼制药-B03月07日遭主力抛售409万元
市场透视 · 03-07
歌礼制药-B03月07日遭主力抛售409万元
港股异动 | 歌礼制药-B(01672)涨超5% ASC30、ASC47均具备差异化设计方式 产品发展未来可期
智通财经 · 03-06
港股异动 | 歌礼制药-B(01672)涨超5% ASC30、ASC47均具备差异化设计方式 产品发展未来可期
歌礼制药-B盘中异动 股价大涨5.14%
市场透视 · 03-06
歌礼制药-B盘中异动 股价大涨5.14%
【券商聚焦】中信建投维持歌礼制药(01672)“买入”评级 指减重、降脂药物未来可期
金吾财讯 · 03-05
【券商聚焦】中信建投维持歌礼制药(01672)“买入”评级 指减重、降脂药物未来可期
歌礼制药-B盘中异动 早盘股价大涨5.00%报7.560港元
市场透视 · 03-05
歌礼制药-B盘中异动 早盘股价大涨5.00%报7.560港元
歌礼制药-B(1672.HK):早期临床研发取得突破 GLP1口服药物值得关注
中信建投证券 · 03-04
歌礼制药-B(1672.HK):早期临床研发取得突破 GLP1口服药物值得关注
公司概况
公司名称:
歌礼制药-B
所属市场:
SEHK
上市日期:
2018-08-01
主营业务:
歌礼制药有限公司是一家主要从事医药产品的研发、生产、营销及销售的中国投资控股公司。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。病毒性疾病产品管线包括利托那韦、盐酸拉维达韦、达诺瑞韦钠等。非酒精性脂肪性肝炎产品管线包括ASC40、ASC41、ASC42等。肿瘤产品管线包括ASC60、ASC61等。
发行价格:
14.000
{"stockData":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"歌礼制药-B","latestPrice":4.94,"timestamp":1744877289029,"preClose":5.18,"halted":0,"volume":6790208,"delay":0,"floatShares":963000000,"shares":963000000,"eps":-0.31988525926385797,"marketStatus":"复活节星期一休市","change":-0.24,"latestTime":"04-17 16:08:09","open":5.18,"high":5.29,"low":4.9,"amount":34358460,"amplitude":0.07529,"askPrice":4.98,"askSize":1000,"bidPrice":4.94,"bidSize":3000,"shortable":0,"etf":0,"ttmEps":-0.31988525926385797,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":5.18,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":0.8723060635101935,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01672/wiki","defaultTab":"wiki","newsList":[{"id":"2529268819","title":"歌礼制药-B:斥资回购,股权行使","url":"https://stock-news.laohu8.com/highlight/detail?id=2529268819","media":"和讯网","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529268819?lang=zh_cn&edition=full","pubTime":"2025-04-21 09:21","pubTimestamp":1745198505,"startTime":"0","endTime":"0","summary":"【歌礼制药-B 于 2025 年 4 月 17 日有重要财经动作】2025 年 4 月 17 日,歌礼制药-B 斥资 49.66 万港元回购 10 万股。同日,因购股权获行使发行合计 11.9 万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421093458973ecad3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421093458973ecad3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01477","BK1574","01672","BK1161"],"gpt_icon":0},{"id":"2528711048","title":"歌礼制药-B(01672)4月17日斥资49.66万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2528711048","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528711048?lang=zh_cn&edition=full","pubTime":"2025-04-17 20:32","pubTimestamp":1744893178,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B(01672)发布公告,于2025年4月17日斥资49.66万港元回购10万股。于2025年4月17日,因购股权获行使发行合计11.9万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1280381.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","01477","BK1191","01672","BK1161"],"gpt_icon":0},{"id":"2528735815","title":"歌礼制药-B盘中异动 早盘股价大跌5.02%报4.920港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528735815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528735815?lang=zh_cn&edition=full","pubTime":"2025-04-17 10:14","pubTimestamp":1744856043,"startTime":"0","endTime":"0","summary":"2025年04月17日早盘10时14分,歌礼制药-B股票出现异动,股价急速下挫5.02%。截至发稿,该股报4.920港元/股,成交量303.1万股,换手率0.31%,振幅7.14%。资金方面,该股资金流入426.184万港元,流出1014.6万港元。机构评级方面,在所有4家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。歌礼制药-B股票所在的生物技术行业中,整体跌幅为0.06%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417101404973aa122&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417101404973aa122&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1191","BK1515","01672","01477","BK1574"],"gpt_icon":0},{"id":"2527987297","title":"歌礼制药-B(01672)4月16日斥资51.91万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2527987297","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527987297?lang=zh_cn&edition=full","pubTime":"2025-04-16 19:23","pubTimestamp":1744802612,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B(01672)发布公告,于2025年4月16日斥资51.91万港元回购股份10万股,每股回购价格为5.11-5.3港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1279655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","01672","BK1161","BK1574","BK1191","01477"],"gpt_icon":0},{"id":"2527260014","title":"歌礼制药-B04月16日遭主力抛售392万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527260014","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527260014?lang=zh_cn&edition=full","pubTime":"2025-04-16 16:16","pubTimestamp":1744791380,"startTime":"0","endTime":"0","summary":"04月16日, 歌礼制药-B股价跌17.12%,报收5.18元,成交金额4544万元,换手率0.88%,振幅18.72%,量比1.10。歌礼制药-B今日主力资金净流出392万元,上一交易日主力净流出88万元。该股近5个交易日上涨5.28%,主力资金累计净流出189万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1261万元,其中净流入天数为10日。该股主力净额占比0.08%,港股市场排名2593/2650。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416173733a45aeb08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416173733a45aeb08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","01672","BK1574","BK1515","BK1191","BK1161"],"gpt_icon":0},{"id":"2527728439","title":"港股医药股持续走弱,歌礼制药跌超10%,药明生物跌超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527728439","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527728439?lang=zh_cn&edition=full","pubTime":"2025-04-16 11:18","pubTimestamp":1744773509,"startTime":"0","endTime":"0","summary":"港股医药股持续走弱,歌礼制药跌超10%,药明生物跌超5%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504163378425038.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504163378425038.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1242518931.SGD","LU0572944931.SGD","LU0326950275.SGD","LU0823426480.USD","02269","LU0181495838.USD","01477","LU0348735423.USD","BK1515","LU0348825331.USD","SG9999002562.SGD","LU0327786744.USD","LU0052750758.USD","LU0417516738.SGD","LU0856984785.SGD","LU0320764599.SGD","LU2039709279.SGD","BK1576","BK1574","LU0516422440.USD","LU0417516902.SGD","LU1720050803.USD","LU0359202008.SGD","LU0039217434.USD","LU0979878070.USD","LU1880383366.USD","BK1141","BK1191","LU0307460666.USD","BK1161","LU0359201612.USD","LU0140636845.USD","LU0708995583.HKD","LU1794554557.SGD","LU0823426308.USD","LU0516423174.USD","BK1610","LU0516423091.SGD","LU0819121731.USD","LU1242518857.USD","LU1688375341.USD","IE00B0JY6N72.USD","01672","SG9999002463.SGD","BK1521","LU0051755006.USD","LU0456827905.SGD","LU0456846285.SGD","LU0516422366.SGD","LU0516422952.EUR"],"gpt_icon":0},{"id":"2527402821","title":"歌礼制药-B盘中异动 股价大跌5.28%报5.920港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527402821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527402821?lang=zh_cn&edition=full","pubTime":"2025-04-16 09:37","pubTimestamp":1744767432,"startTime":"0","endTime":"0","summary":"2025年04月16日早盘09时37分,歌礼制药-B股票出现波动,股价大幅跳水5.28%。截至发稿,该股报5.920港元/股,成交量9.8998万股,换手率0.01%,振幅5.44%。歌礼制药-B股票所在的生物技术行业中,整体跌幅为0.47%。其相关个股中,复宏汉霖、云康集团、盛禾生物-B涨幅较大,振幅较大的相关个股有康诺亚-B、歌礼制药-B、复宏汉霖,振幅分别为5.30%、4.80%、4.71%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041609371297393a94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041609371297393a94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","01672","BK1191","BK1515","BK1574","BK1161"],"gpt_icon":0},{"id":"2527911084","title":"歌礼制药-B(01672)因购股权获行使 合计发行11.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2527911084","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527911084?lang=zh_cn&edition=full","pubTime":"2025-04-15 19:15","pubTimestamp":1744715753,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B(01672)发布公告,由于合资格参与者根据本公司于2019年6月6日采纳的购股权计划行使购股权,本公司于2025年4月15日发行3.3万股普通股。由于合资格参与者根据本公司于2019年6月6日采纳的购股权计划行使购股权,本公司于2025年4月15日发行8万股普通股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1279015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01477","01672","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"2527486073","title":"港股异动 | 歌礼制药-B(01672)早盘涨超12% 去年公司管线做出重大战略调整 减肥药物效果优异","url":"https://stock-news.laohu8.com/highlight/detail?id=2527486073","media":"智通财经网","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527486073?lang=zh_cn&edition=full","pubTime":"2025-04-15 11:19","pubTimestamp":1744687140,"startTime":"0","endTime":"0","summary":"歌礼制药-B早盘涨超12%,截至发稿,涨12.31%,报6.48港元,成交额1956.19万港元。光大证券发布研报称,2024年,歌礼制药对于公司管线做出重大战略调整。同时公司新增肥胖及代谢性疾病临床管线,分别是GLP受体激动剂ASC30与THR-β激动剂ASC47,截至24年末,二者在海外均已推进至临床I期。公司口服与皮下注射减肥产品初步展现出优异的减重效果与长半衰期,在同类竞品中具备独特优势。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-15/doc-inetfhry8003767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","01672","01477","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"1194576384","title":"港股生物医药B类股逆势活跃,歌礼制药-B涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194576384","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194576384?lang=zh_cn&edition=full","pubTime":"2025-04-15 10:11","pubTimestamp":1744683073,"startTime":"0","endTime":"0","summary":"港股异动|生物医药B类股逆势活跃,$歌礼制药-B(01672)$涨超8%,$华领医药-B(02552)$、$东曜药业-B(01875)$涨近5%,$迈博药业-B(02181)$涨超4%","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","BK4614","YANG","01477","HSTECH","BK1161","07226","01875","HSCEI","01672","BK1191","02552","02181"],"gpt_icon":0},{"id":"2527477136","title":"歌礼制药-B04月14日主力净流入224万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2527477136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527477136?lang=zh_cn&edition=full","pubTime":"2025-04-14 16:17","pubTimestamp":1744618636,"startTime":"0","endTime":"0","summary":"04月14日, 歌礼制药-B股价涨7.65%,报收5.77元,成交金额4521万元,换手率0.82%,振幅7.65%,量比0.83。歌礼制药-B今日主力资金净流入224万元,上一交易日主力净流出36万元。该股近5个交易日上涨16.57%,主力资金累计净流入208万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入2073万元,其中净流入天数为11日。该股主力净额占比0.04%,港股市场排名142/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414171559a6b9dc6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414171559a6b9dc6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","01672","BK1191","BK1574","BK1161","BK1515"],"gpt_icon":0},{"id":"2527694366","title":"歌礼制药-B盘中异动 快速上涨6.34%报5.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527694366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527694366?lang=zh_cn&edition=full","pubTime":"2025-04-14 09:30","pubTimestamp":1744594218,"startTime":"0","endTime":"0","summary":"2025年04月14日早盘09时30分,歌礼制药-B股票出现异动,股价大幅拉升6.34%。截至发稿,该股报5.700港元/股,成交量11.3万股,换手率0.01%,振幅3.73%。歌礼制药-B股票所在的生物技术行业中,整体涨幅为1.16%。其相关个股中,再鼎医药、药明合联、歌礼制药-B涨幅较大,振幅较大的相关个股有药明合联、腾盛博药-B、再鼎医药,振幅分别为6.09%、4.94%、4.50%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504140930189736e718&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504140930189736e718&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1515","BK1161","BK1191","01477","BK1574"],"gpt_icon":0},{"id":"2518179734","title":"歌礼制药-B03月11日主力净流入124万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2518179734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518179734?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:17","pubTimestamp":1741681059,"startTime":"0","endTime":"0","summary":"03月11日, 歌礼制药-B股价涨1.38%,报收7.35元,成交金额2890万元,换手率0.41%,振幅8.69%,量比0.43。歌礼制药-B今日主力资金净流入124万元,上一交易日主力净流出234万元。该股近5个交易日上涨2.08%,主力资金累计净流出582万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入2865万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311170647abf60d9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311170647abf60d9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1191","BK1161","01477","BK1515","BK1574"],"gpt_icon":0},{"id":"2518731994","title":"歌礼制药-B盘中异动 股价大跌5.93%报6.820港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518731994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518731994?lang=zh_cn&edition=full","pubTime":"2025-03-11 09:33","pubTimestamp":1741656819,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘09时33分,歌礼制药-B股票出现波动,股价快速下挫5.93%。截至发稿,该股报6.820港元/股,成交量9.8万股,换手率0.01%,振幅5.79%。资金方面,该股资金流入14.575万港元,流出41.807万港元。歌礼制药-B股票所在的生物技术行业中,整体跌幅为0.07%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110933399640ca46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110933399640ca46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01477","BK1574","BK1161","BK1515","01672"],"gpt_icon":0},{"id":"2517110937","title":"歌礼制药-B03月07日遭主力抛售409万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517110937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517110937?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:17","pubTimestamp":1741335427,"startTime":"0","endTime":"0","summary":"03月07日, 歌礼制药-B股价跌2.82%,报收6.90元,成交金额3108万元,换手率0.46%,振幅4.51%,量比0.36。歌礼制药-B今日主力资金净流出409万元,上一交易日主力净流出109万元。该股近5个交易日上涨4.55%,主力资金累计净流入230万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入3071万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170955a263e10f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170955a263e10f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","BK1161","01672","01477","BK1515"],"gpt_icon":0},{"id":"2517908031","title":"港股异动 | 歌礼制药-B(01672)涨超5% ASC30、ASC47均具备差异化设计方式 产品发展未来可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2517908031","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517908031?lang=zh_cn&edition=full","pubTime":"2025-03-06 10:22","pubTimestamp":1741227746,"startTime":"0","endTime":"0","summary":"中信建投发布研报称,歌礼制药-B发布公告,其GLP-1R激动剂ASC30在美国Ib期临床试验取得积极成果。数据显示,前两个列队中ASC30经安慰剂组校准后分别使体重下降4.2%和6.2%,并且安全性良好。该行认为,全球减重药物市场规模蓬勃成长,众多超重或肥胖成年人群急需创新药物来改善并提高生活质量,在此基础下,公司的两款药物ASC30、ASC47均具备差异化设计方式,产品发展未来可期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","BK1515","01672","01477","BK1161"],"gpt_icon":0},{"id":"2517908542","title":"歌礼制药-B盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517908542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517908542?lang=zh_cn&edition=full","pubTime":"2025-03-06 10:19","pubTimestamp":1741227599,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘10时19分,歌礼制药-B股票出现波动,股价急速上涨5.14%。截至发稿,该股报7.360港元/股,成交量325.1万股,换手率0.34%,振幅5.29%。资金方面,该股资金流入953.631万港元,流出1142.22万港元。歌礼制药-B股票所在的生物技术行业中,整体涨幅为2.00%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306102000a261980a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306102000a261980a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","01477","BK1574","BK1191","01672"],"gpt_icon":0},{"id":"2517496089","title":"【券商聚焦】中信建投维持歌礼制药(01672)“买入”评级 指减重、降脂药物未来可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2517496089","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517496089?lang=zh_cn&edition=full","pubTime":"2025-03-05 16:16","pubTimestamp":1741162593,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研报指,歌礼制药 发布公告,其GLP-1R激动剂ASC30在美国Ib期临床试验取得积极成果。数据显示,前两个列队中ASC30经安慰剂组校准后分别使体重下降4.2%和6.2%,并且安全性良好。该行认为,全球减重药物市场规模蓬勃成长,众多超重或肥胖成年人群急需创新药物来改善并提高生活质量,在此基础下,公司的两款药物ASC30、ASC47均具备差异化设计方式,产品发展未来可期。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954421","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","01672"],"gpt_icon":0},{"id":"2517932590","title":"歌礼制药-B盘中异动 早盘股价大涨5.00%报7.560港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517932590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517932590?lang=zh_cn&edition=full","pubTime":"2025-03-05 09:39","pubTimestamp":1741138743,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时39分,歌礼制药-B股票出现波动,股价大幅拉升5.00%。截至发稿,该股报7.560港元/股,成交量41.2万股,换手率0.04%,振幅4.86%。歌礼制药-B股票所在的生物技术行业中,整体涨幅为1.12%。其相关个股中,康宁杰瑞制药-B、再鼎医药、科笛-B涨幅较大,振幅较大的相关个股有康宁杰瑞制药-B、科笛-B、和誉-B,振幅分别为7.63%、7.59%、7.42%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093903a25fc2bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093903a25fc2bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01672","BK1161","BK1574","BK1191","01477"],"gpt_icon":0},{"id":"2517937639","title":"歌礼制药-B(1672.HK):早期临床研发取得突破 GLP1口服药物值得关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2517937639","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517937639?lang=zh_cn&edition=full","pubTime":"2025-03-05 00:00","pubTimestamp":1741104000,"startTime":"0","endTime":"0","summary":"数据显示,前两个列队中ASC30 经安慰剂组校准后分别使体重下降4.2%和6.2%,并且安全性良好。事件公司发布公告,GLP-1R 激动剂ASC30 在美国Ib 期临床试验取得积极结果。ASC30:发布Ib 期多剂量递增研究结果,前两个队列疗效、安全性表现积极ASC30 是一款正在临床研究中的小分子GLP-1R 偏向激动剂,具有独特和差异化特性,使得同一小分子同时适用于皮下注射和口服片剂给药成为可能。安慰剂组体重下降0.1%,ASC30 组经安慰剂校准后的体重下降为6.2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305100124a25fcc58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305100124a25fcc58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01477","BK1161","BK1574","01672"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascletis.com","stockEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":-0.3961},{"period":"3month","weight":0.2831},{"period":"6month","weight":2.7424},{"period":"1year","weight":2.8},{"period":"ytd","weight":0.6412}],"compareEarnings":[{"period":"1week","weight":0.0345},{"period":"1month","weight":-0.1352},{"period":"3month","weight":0.0925},{"period":"6month","weight":0.0284},{"period":"1year","weight":0.3165},{"period":"ytd","weight":0.0666}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"歌礼制药有限公司是一家主要从事医药产品的研发、生产、营销及销售的中国投资控股公司。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。病毒性疾病产品管线包括利托那韦、盐酸拉维达韦、达诺瑞韦钠等。非酒精性脂肪性肝炎产品管线包括ASC40、ASC41、ASC42等。肿瘤产品管线包括ASC60、ASC61等。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.137639},{"month":2,"riseRate":0.714286,"avgChangeRate":0.094063},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.058802},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.084203},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.025765},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.058787},{"month":7,"riseRate":0.5,"avgChangeRate":0.006985},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.090298},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.044648},{"month":10,"riseRate":0.571429,"avgChangeRate":-0.021896},{"month":11,"riseRate":0.857143,"avgChangeRate":0.138187},{"month":12,"riseRate":0.571429,"avgChangeRate":0.13144}],"exchange":"SEHK","name":"歌礼制药-B","nameEN":"ASCLETIS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"歌礼制药-B,01672,歌礼制药-B股票,歌礼制药-B股票老虎,歌礼制药-B股票老虎国际,歌礼制药-B行情,歌礼制药-B股票行情,歌礼制药-B股价,歌礼制药-B股市,歌礼制药-B股票价格,歌礼制药-B股票交易,歌礼制药-B股票购买,歌礼制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}